Ensysce Biosciences Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Ensysce Biosciences shares have resumed trading after a temporary halt.

November 30, 2023 | 7:44 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ensysce Biosciences shares have resumed trading, which could lead to increased volatility as the market reacts to the resumption.
The resumption of trading typically leads to a period of price discovery as investors and traders reassess the stock's value. This can cause short-term volatility, but without additional context or news driving the halt, the direction of the price movement is uncertain.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100